Links between non-alcoholic fatty lever disease and subclinical atherosclerosis
Keywords:
atherosclerosis, subclinical atherosclerosis, fatty lever, hepatic steatosisAbstract
Introduction: non-alcoholic fatty lever disease is linked to atherosclerosis due to the latest´s risk factors. There are also tendencies that affirm that there is a different factor on its pathogeny. The subclinical atherosclerosis is a preventive medicine concept, and looking for it can help finding clues for future irreversible damage. Objective: to determine the association between subclinical atherosclerosis in dyslipidemic patients with non-alcoholic fatty lever disease. Method: a descriptive, cross-sectional study was carried out in a population of 114 dyslipidemic patients with non-alcoholic fatty lever disease in the dyslipoproteinemias consultation at the Surgical Clinical Hospital ¨Hermanos Amejeiras¨ from 2016 to 2019. Results: mean age was 52.9 ± 12.4 years, with male patients’ predominance. 62 patients showed thickening in the intima-media wider than 1mm in echocardiography, and just 8 patients had atheroma plaque in the carotid artery. The frequency of the altered lipidic profile was due to hypertriglyceridaemia and HDL cholesterol. Conclusions: no link was found between non-alcoholic fatty lever disease and subclinical atherosclerosis. Through the analysis, atherosclerosis was linked to variables as age and family history of ischemic heart disease. There is no association between subclinical atherosclerosis and the degree of progression in the non-alcoholic fatty lever disease given by the APRI index.
Downloads
References
Herrera A, Nasiff A, Arus E, Cand C, León N. Hígado graso. Enfoque diagnóstico y terapéutico. Rev Cubana Med [en línea] 2007 [citado 20 Mar 2020]; 46(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232007000100009
Petta S, Valenti L, Bugianesi E, Targher G, Bellentani S, Bonino F. A “systems medicine” approach to the study of non-alcoholic fatty liver disease. Rev Dig Liver Dis [en línea]. 2015 [citado 20 Mar 2020]; 27(5):1590-1601. Disponible en: https://iris.unipa.it/retrieve/handle/10447/159261/253460/PETTA%20DLD%202016.pdf
Lonardo A, Ballestri S, Marchesini G, Angulo P, Loria P. Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. Dig Liver Dis [en línea] 2015 [citado 20 Mar 2020]; 47(3):181–90. Disponible en: https://pubmed.ncbi.nlm.nih.gov/25739820/
Duseja T. Non-alcoholic Fatty Liver Disease and Metabolic Syndrome Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. J Clin Exp Hepatol [en línea]. 2015 [citado 20 Mar 2020]; 5(1):51-68. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415196/
Sven M. Francque, Denise van der Graaff, Wilhelmus J. Kwanten. Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications. J Hepatology [en línea]. 2016 [citado 20 Mar 2020]; 65:425–43. Disponible en: https://www.journal-of-hepatology.eu/article/S0168-8278(16)30107-6/pdf
Paris Edison Roberto. Nonalcoholic fatty liver disease (NAFLD), more than a liver disease. Arq. Gastroenterol. [en línea] 2019 [citado 2 May 2020]; 56(3). Disponible en: https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032019000300243
Anca D. Farcaş1, Camelia Larisa Vonica2, Adela C. Golea3. Non-alcoholic fatty liver disease, bulb carotid intima-media thickness and obesity phenotypes: results of a prospective observational study. Med Ultr [en línea]. 2017 [citado 2 May 2020]; 19(3):265-71. Disponible en: https://www.medultrason.ro/medultrason/index.php/medultrason/article/viewFile/1015/995
Lankarani P.Non Alcoholic Fatty Liver Disease in Southern Iran: A Population Based Study. Hepat Mon [en línea] 2013 [citado 2 May 2020]; 13(5):9248. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734894/
Kim Hyun-Jin.Gender-based differences in the relationship between fatty liver disease and atherosclerosis. Cardiovasc J Afr [en línea] 2016 [citado 2 May 2020]; 27(5):281–86. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370319/
Yun Huang, Yufang Bi, Min Xu, Zhimin Ma, Yu Xu, Tiange Wang, Mian Li, Yu Liu, Jieli Lu, Yuhong Chen, Fei Huang, Baihui Xu, Jie Zhang, Weiqing Wang, Xiaoying Li, Guang Ning. Nonalcoholic Fatty Liver Disease Is Associated With Atherosclerosis in Middle-Aged and Elderly Chinese. Arteriosc Throm Vasc Biol [en línea]. 2012 [citado 2 May 2020]; 32(9):2321-6. Disponible en: https://pubmed.ncbi.nlm.nih.gov/22814750/
Xin Xu, Linlin Lu, Quanyong Dong, Xiaolin Li, Nannan Zhang, Yongning Xin, Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis. Lipids Health Dis [en línea]. 2015 [citado 2 May 2020]; 14:158. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668687/
Gummesson A, Strömberg U, Schmidt C, Kullberg J, Angerås O, Lindgren S,Hjelmgren O, Torén K, Rosengren A, Fagerberg B, Brandberg J, Bergström G. Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects. Europe PMC [en línea]. 2018 [citado 2 May 2020]; 13(8):e0202666 Disponible en: https://europepmc.org/article/pmc/pmc6105021
Wenjie Dai, MD, Ling Ye, MD, Aizhong Liu, PhD, Shi Wu Wen, PhD, Jing Deng, MD, Xin Wu, MM, Zhiwei Lai, MM. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Medicine (Baltimore) [en línea]. 2017 [citado 2 May 2020] 96(39):e8179. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626318/
Madan SA, John F, Pyrsopoulos N, Pitchumoni CS. Nonalcoholic fatty liver disease and carotid artery atherosclerosis in children and adults: a metaanalysis. Eur J Gastroentreol Hepatol [en línea]. 2015 [citado 2 May 2020]; 27(11):1237–48. Disponible en: https://europepmc.org/article/med/26193052
Ampuero T, Gallego-Durán Rocío, Romero-Gómez Manuel. Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: Meta-analysis. Rev Esp Enferm Dig (Madrid). [en línea] 2015; [citado 2 May 2020]; 107(1):10-16. Disponible en: http://scielo.isciii.es/pdf/diges/v107n1/original2.pdf
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Alfredo Herrera-González, Donel González-Díaz, Yaranis Hernández-Oria, Katsuyori Pérez-Mola, Jesús Daniel de la Rosa-Santana
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The Gaceta Médica Estudiantil magazine provides immediate Open Access to its content. It is published under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC) license, which allows sharing (copying and redistributing the material in any medium or format) and adapting (remixing, transforming, and building upon the material), under the terms of acknowledge authorship and not make commercial use of the materials.
